The Therapeutic Goods Administration issued the company seven infringement notices totaling $93,240 for promoting its nasal spray, Viraleze, via its website and YouTube channel.
Starpharma issued a statement on Monday, and said the company"immediately acted" after they found out.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
While most would find such a fine nothing to sneeze at, a global company would probably thumb their nose at the idea of it being a problem.